GlaxoSmithKline S.A.E. (BIOC) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 14:30 (Cairo time).
What is GlaxoSmithKline S.A.E.’s share price today? BIOC last traded at EGP 281.03 (+8.83% on the day), for a market value of EGP 23.47 billion and a dividend yield of 0.18%. Its 52-week range is EGP 55.1 to 609.
Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.
GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.
Data as of 28 Oct 2026, 14:30 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).